These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 3101564)
1. [Thromboembolic disease and anomalies of fibrinolysis]. Juhan-Vague I; Aillaud MF; Valadier J; Alessi MC; Serradimigni A Ann Med Interne (Paris); 1986; 137(6):471-4. PubMed ID: 3101564 [TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
4. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma. Brommer EJ; Verheijen JH; Chang GT; Rijken DC Thromb Haemost; 1984 Oct; 52(2):154-6. PubMed ID: 6441302 [TBL] [Abstract][Full Text] [Related]
5. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Francis RB; McGehee WG; Feinstein DI Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079 [TBL] [Abstract][Full Text] [Related]
6. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man. Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078 [TBL] [Abstract][Full Text] [Related]
7. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism. Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786 [TBL] [Abstract][Full Text] [Related]
8. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059 [TBL] [Abstract][Full Text] [Related]
9. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Kluft C; Jie AF; Rijken DC; Verheijen JH Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814 [TBL] [Abstract][Full Text] [Related]
10. Diurnal variation of the fibrinolytic system. Grimaudo V; Hauert J; Bachmann F; Kruithof EK Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085 [TBL] [Abstract][Full Text] [Related]
11. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients. Sultan Y; Harris A; Strauch G; Venot A; De Lauture D J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470 [TBL] [Abstract][Full Text] [Related]
12. [Differentiation of a normal population and of a cohort of patients presenting with a history of idiopathic thromboembolism as identified with fibrinolytic tests]. Nicoloso G; Hauert J; Kruithof EK; van Melle G; Bachmann F Schweiz Med Wochenschr; 1988 Jan; 118(4):122-4. PubMed ID: 3125604 [TBL] [Abstract][Full Text] [Related]
13. Plasma fibrinolytic activity in patients undergoing major abdominal surgery. Mellbring G; Dahlgren S; Wiman B Acta Chir Scand; 1985; 151(2):109-14. PubMed ID: 3873768 [TBL] [Abstract][Full Text] [Related]
14. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. Juhan-Vague I; Vague P; Alessi MC; Badier C; Valadier J; Aillaud MF; Atlan C Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812 [TBL] [Abstract][Full Text] [Related]
16. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies. Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431 [TBL] [Abstract][Full Text] [Related]
18. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay. Anglés-Cano E; Boutière B; Arnoux D; Masson C; Contant G; Benchimol P; Sampol J Thromb Haemost; 1987 Oct; 58(3):843-9. PubMed ID: 3124285 [TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects. MacGregor IR; Roberts EM; Prowse CV; Broomhead AF; Ozolins M; Litka P Thromb Haemost; 1988 Feb; 59(1):34-9. PubMed ID: 3129807 [TBL] [Abstract][Full Text] [Related]
20. Altered fibrinolysis in DVT: influence of site of sampling. Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]